Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England.
Helen L ReevesJohn ReicherGeorgia PrionaDerek M ManasPeter LittlerPublished in: Frontline gastroenterology (2022)
SIRT outcomes for advanced HCC, often bridging patients with adverse predictive factors to subsequent surgery or medical therapies, were encouraging. A role after TACE or for BCLC-C patients requires further assessment.
Keyphrases
- radiation therapy
- end stage renal disease
- clinical practice
- newly diagnosed
- chronic kidney disease
- ejection fraction
- oxidative stress
- minimally invasive
- prognostic factors
- ischemia reperfusion injury
- type diabetes
- peritoneal dialysis
- squamous cell carcinoma
- metabolic syndrome
- atrial fibrillation
- surgical site infection